<DOC>
	<DOCNO>NCT02424474</DOCNO>
	<brief_summary>The purpose study evaluate performance non invasive screen population pregnant woman without vitro fertilisation ( IVF ) concomitantly regular first trimester trisomy 21 ( T21 ) screen use maternal age , nucal fold measurement serum screening .</brief_summary>
	<brief_title>T21,18 13 Screening Cell Free Fetal DNA Low Risk Patients</brief_title>
	<detailed_description>All pregnant woman 9 institution France offer regular first trimester screen trisomy 21 ( T21 ) cell free DNA non invasive ( NI ) screen test time . Specificity positive negative predictive value NI test analyse . The population divide woman get pregnant In vitro fertilisation ( IVF ) procedure .</detailed_description>
	<mesh_term>Trisomy</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Age &gt; 18 Singleton pregnancy Having spontaneous pregnancy obtain AMP , Having choose carry screen T21 first second trimester pregnancy , Gestational age &gt; =10 week amenorrhea Consenting invasive prenatal diagnosis , Having health insurance , Having sign informed consent The Patients whose fetus abnormality first trimester ultrasound include nuchal translucency &gt; 3.5mm , Participant another biomedical research . Pregnancy twin include presence twin vanish</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cell free fetal DNA</keyword>
	<keyword>general population</keyword>
	<keyword>screen</keyword>
	<keyword>trisomy 21</keyword>
	<keyword>IVF</keyword>
</DOC>